Global Medical Imaging Contrast Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Imaging Contrast Market Research Report 2024
Medical imaging contrast refers to substances or agents used to enhance the visibility and differentiation of structures or regions within the body during various medical imaging procedures. These substances increase the contrast between different tissues or fluids, allowing healthcare professionals to obtain clearer and more detailed images, aiding in diagnosis, treatment planning, and monitoring of medical conditions.
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
According to Mr Accuracy reports’s new survey, global Medical Imaging Contrast market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029.
Key manufacturers engaged in the Medical Imaging Contrast industry include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Medical Imaging Contrast were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medical Imaging Contrast market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Imaging Contrast market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Hospitals
Clinics
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Imaging Contrast report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
According to Mr Accuracy reports’s new survey, global Medical Imaging Contrast market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029.
Key manufacturers engaged in the Medical Imaging Contrast industry include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Medical Imaging Contrast were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medical Imaging Contrast market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Imaging Contrast market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Imaging Contrast report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source